Keros Therapeutics, Inc. - Filer Information

Symbol
KROS on Nasdaq
Entity
Company
CIK
0001664710
EIN
811173868
Business address
1050 Waltham Street, Suite 302, 02421 Lexington, MA
Phone
617-314-6297
Fiscal year end
December 31
Category
Large accelerated filer
All SEC filings
View on sec.gov
Get insider transactions for this issuer
Get financial reports for this company